Isabelle Germano, MD, MBA

Daniel Nathan, MD is a Cancer (Oncology) provider with Mount Sinai Health System, treating patients in the New York area. Dr. Nathan is committed to compassionate, coordinated care that supports patients throughout the diverse communities we serve.

Max Sung, MD, is Associate Professor of Medicine (Hematology and Medical Oncology) at the Icahn School of Medicine at Mount Sinai. He has been on the faculty at Mount Sinai since 1987. Dr. Sung specializes in gastrointestinal cancers including liver, bile duct, pancreas, esophagus, stomach, colon/rectum, and anus cancers. His approach to cancer treatment is multi-disciplinary, and involves collaboration with other specialties such as surgery, interventional radiology, and radiation therapy. Dr. Sung has held numerous leadership roles at Mount Sinai, including Medical Director of The Ruttenberg Treatment Center and Chair of the Data and Safety Monitoring Committee for cancer clinical trials. Dr. Sung is involved in clinical cancer research and has authored numerous peer-reviewed publications on innovative and translational treatments. Dr. Sung is fluent in English and Chinese (Cantonese and Mandarin), and has a working knowledge of German and French.

Dr. Friedlander received medical school training at Columbia University where he obtained his M.D. and Ph.D. degree in Biology. He remained at Columbia Presbyterian Medical Center to complete his postdoctoral training in Internal Medicine and subsequently completed a clinical fellowship in Medical Oncology at Memorial Sloan Kettering Cancer Center. He then joined the faculty of the Dana Farber Cancer Institute/Brigham and Women’s Hospital as an attending physician within the Melanoma and Cutaneous Oncology Programs and as an Instructor of Medicine at Harvard Medical School.